Nutrien (NYSE:NTR – Get Free Report) released its earnings results on Wednesday. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.09), Zacks reports. The business had revenue of $5.08 billion for the quarter, compared to analyst estimates of $5.09 billion. Nutrien had a return on equity of 6.99% and a net margin of 2.79%.
Nutrien Price Performance
NTR traded up $0.97 during midday trading on Thursday, reaching $53.42. 693,213 shares of the company’s stock were exchanged, compared to its average volume of 2,234,598. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The stock has a market capitalization of $26.17 billion, a PE ratio of 35.83, a P/E/G ratio of 1.16 and a beta of 0.81. The business’s 50-day moving average price is $49.22 and its 200 day moving average price is $48.16. Nutrien has a 1-year low of $43.69 and a 1-year high of $60.87.
Analyst Upgrades and Downgrades
NTR has been the topic of a number of research reports. JPMorgan Chase & Co. upgraded shares of Nutrien from an “underweight” rating to a “neutral” rating and increased their target price for the stock from $40.00 to $50.00 in a report on Monday, January 13th. Piper Sandler increased their target price on shares of Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. CIBC reiterated an “outperformer” rating and set a $55.00 target price (down from $60.00) on shares of Nutrien in a report on Tuesday, December 10th. UBS Group increased their target price on shares of Nutrien from $53.00 to $54.00 and gave the stock a “neutral” rating in a report on Thursday. Finally, TD Securities reduced their price objective on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a report on Tuesday, November 12th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $59.06.
About Nutrien
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Stories
- Five stocks we like better than Nutrien
- What is a Bond Market Holiday? How to Invest and Trade
- Tesla: 2 Reasons to Buy, 1 Reason to Run
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Should You Hold Nvidia Stock for the Long Haul or Trade It?
- What Does a Stock Split Mean?
- Humana Gains Despite Medicare Advantage Losses—What’s the Catch?
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.